Growth Metrics

Soleno Therapeutics (SLNO) Other financing activities (2014 - 2025)

Soleno Therapeutics (SLNO) reported Other financing activities of $679000.0 for Q4 2025, up 1957.58% on a QoQ basis from $33000.0 in Q2 2025.

Soleno Therapeutics (SLNO) has 8 years of Other financing activities data on file, last reported at $679000.0 in Q4 2025.

  • Quarterly Other financing activities changed N/A year-over-year to $679000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $712000.0 (up 259.6% YoY) and the FY2025 annual result came in at $741000.0, changed N/A from the prior year.
  • Other financing activities grew to $679000.0 in Q4 2025 per SLNO's latest filing, from $33000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $679000.0 in Q4 2025 and bottomed at $16000.0 in Q1 2022.
  • The 3-year median for Other financing activities is $62000.0 (2025), against an average of $182000.0.
  • Peak annual rise in Other financing activities reached 86.67% in 2022, while the deepest fall reached 86.67% in 2022.
  • Tracing SLNO's Other financing activities over 3 years: stood at $120000.0 in 2021, then tumbled by 86.67% to $16000.0 in 2022, then jumped by 4143.75% to $679000.0 in 2025.
  • Per Business Quant, the three latest SLNO Other financing activities figures stand at $679000.0 (Q4 2025), $33000.0 (Q2 2025), and $62000.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 679,000.00
Dec 31, 2025 679,000.00
Jun 30, 2025 33,000.00
Jun 30, 2025 33,000.00
Mar 31, 2025 62,000.00
Mar 31, 2025 62,000.00
Mar 31, 2022 16,000.00
Mar 31, 2022 16,000.00
Mar 31, 2021 120,000.00
Mar 31, 2021 120,000.00
Sep 30, 2018 700,000.00
Sep 30, 2018 700,000.00
Jun 30, 2018 425,000.00
Jun 30, 2018 425,000.00
Mar 31, 2018 400,000.00
Mar 31, 2018 400,000.00
Dec 31, 2017 225,000.00
Dec 31, 2017 225,000.00
Jun 30, 2016 -71,000.00
Jun 30, 2016 -71,000.00
Mar 31, 2016 71,000.00
Mar 31, 2016 71,000.00
Dec 31, 2015 45,181.00
Dec 31, 2015 45,181.00
Mar 31, 2015 530,000.00
Mar 31, 2015 530,000.00
Dec 31, 2014 1.84 Mn
Dec 31, 2014 1.84 Mn
Sep 30, 2014 131,000.00
Sep 30, 2014 131,000.00